Seagen Revenue, Growth & Competitor Profile

DBA SEATTLE GENETICS, INC.
DBA SEATTLE GENETICS INC /WA

Company Profile & Annual Report for Seagen

Access the complete profile.

Seagen Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	21823 30th Drive Se Bothell, WA 98021

Note: Revenues for privately held companies are statistical evaluations.


Seagen's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Seagen's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Seagen is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Seagen Annual Revenue and Growth Rate

Seagen	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Seagen's revenues are gauged from an analysis of company filings.

Seagen's Income Statement (based on Industry Averages)

Seagen P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Seagen is developing and marketing. Seagen doesn't have any recent trademark applications, indicating Seagen is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LET'S TALK BLADDER CANCER Providing healthcare information	03/23/2022
TIVDAQ Pharmaceutical preparations for use in humans, namely, chemotherapeutics for the treatment of diseases and conditions; Pharmaceutical preparations for use in humans, namely, biopharmaceuticals for the treatment of diseases and conditions, namely, cancer; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology	04/27/2021
TIVDAKT Pharmaceutical preparations for use in humans, namely, chemotherapeutics for the treatment of diseases and conditions; Pharmaceutical preparations for use in humans, namely, biopharmaceuticals for the treatment of diseases and conditions, namely, cancer; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology	04/27/2021

See all trademarks and details in the Full Report.

Market Share of Seagen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Seagen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Seagen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EXPLORE VENTURES	Kent, WA	100
SEAGEN	Bothell, WA	82
STEMCELL TECHNOLOGIES	Kent, WA	6
INVENTPRISE	Redmond, WA	4
VIOME LIFE SCIENCES	Bellevue, WA	3
GLOBAL HEALTH LABS	Kirkland, WA	3

Future Competition: Seagen's Fastest Growing Competitors

These companies are in the same general field as Seagen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)